2014年《实用肝脏病杂志》精彩回顾

doi:10.3969/j.issn.1672-5069.2015.01.002

Abstract

Fan Jiangao. Highlights of Journal of Practical Hepatology in 2014[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 4-5.

[1] Wang FS,Fan JG,Zhang Z,et al. The global burden of liver disease:the major impact of China. Hepatology,2014,60:2099-2108.
[2] 王晓霞,邹正升,李保森,等. 2002至2011年中国“北方”地区住院肝硬化患者病因构成及变化趋势分析. 实用肝脏病杂志, 2014,17（2）:154-158.
[3] 吴小倩,苏菲. 失代偿期肝硬化患者急性肾损伤相关危险因素分析. 实用肝脏病杂志,2014,17（4）:360-364.
[4] 陈婷,于静,张建民.复合蛋白营养剂治疗乙型肝炎肝硬化患者营养状态及肝功能的变化. 实用肝脏病杂志,2014,17（5）:484-488.
[5] 张野,聂青和. 1892例肝衰竭患者并发症及死亡原因分析. 实用肝脏病杂志,2014,17（2）:129-132.
[6] 张冬琴,张海月,吴吉圆,等. 恩替卡韦与拉米夫定治疗HBV相关性肝衰竭患者疗效Meta分析. 实用肝脏病杂志,2014,17（6）:606-610.
[7] 郝书理,李保森,孙颖,等. 130例酒精性肝衰竭患者临床特点与预后分析. 实用肝脏病杂志,2014,17（2）:136-140.
[8] 郝清亚,王以浪,姚登福,等. 肝癌患者血清microRNA-21水平变化. 实用肝脏病杂志,2014,17（1）:68-70.
[9] 蒋凤,雷宇,钟珊,等.577例原发性肝癌患者临床特征和治疗方案选择分析. 实用肝脏病杂志,2014,17（3）:237-240.
[10] 周萍,孙慧伶,朱肖鸿. 慢性乙型肝炎患者血清HBV DNA载量与肝组织病理学变化关系研究. 实用肝脏病杂志,2014,17（4）:364-367.
[11] 李媚,唐保东,杨琛,等.α-干扰素联合恩替卡韦治疗慢性乙型肝炎患者疗效Meta分析. 实用肝脏病杂志,2014,17（6）:583-587. [12] 陈君,孙晓风,邓泽润,等.妊娠晚期应用替比夫定阻断乙型肝炎病毒宫内感染疗效和安全性的系统评价.实用肝脏病杂志,2014,17（3）:249-254.
[13] 冯振华,张妹,刘景丽,等.慢性HBV携带孕妇产后自发HBeAg和HBsAg血清清除或转换的病毒学因素分析.实用肝脏病杂志,2014,17（4）:376-379.
[14] 李剑萍,关玉娟,洪文昕,等.聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎患者疗效及其影响因素分析. 实用肝脏病杂志, 2014,17（2）:149-153.
[15] 邹正升,赵军,王晓霞,等. 住院的酒精性肝病患者临床疾病特点分析. 实用肝脏病杂志,2014,17（1）:26-29.
[16] 卢加发,刘文斌,潘勤,等. 健康体检成人FibroScan检测肝脏硬度值与受控衰减参数的相关分析. 实用肝脏病杂志,2014,17（5）:484-488.
[17] 彭景,郭艳,何长龙,等. 不明原因肝炎患者临床特征和诊断路径探讨. 实用肝脏病杂志,2014,17（6）:600-605.

Highlights of Journal of Practical Hepatology in 2014

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[3]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[4]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[5]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[6]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[7]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[8]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[9]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[10]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[11]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[12]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[13]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[14]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[15]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.